Society of Nuclear Medicine

Benefits of radionuclide therapy for neuroendocrine tumors

According to new Dutch research featured in the September issue of The Journal of Nuclear Medicine, a peptide receptor radiolabeled therapy (PRRT), [177Lu-DOTA0,Tyr3]Octreotate (177Lu-octreotate) , is effective not only i ...

Sep 20, 2011
popularity 5 / 5 (2) | comments 1

Combined imaging agents advance PET imaging of cancer

Research presented at SNM's 58th Annual Meeting is taking targeted molecular imaging to a new level by combining two commonly used imaging agents into one molecular imaging procedure. The combination of these agents creates ...

Jun 06, 2011
popularity 5 / 5 (1) | comments 0

New pretargeted radioimmunotherapy for colorectal cancer

Investigators at SNM's 58th Annual Meeting are presenting results from a phase 1 clinical trial for a cancer therapy that has the potential to kill colorectal tumors with less destruction of healthy tissue. Further research ...

Jun 06, 2011
popularity 5 / 5 (1) | comments 0

Novel small molecules used to visualize prostate cancer

Two novel radiolabeled small molecules targeting prostate-specific membrane antigen (PSMA) have excellent potential for further development as diagnostic and therapeutic radiopharmaceuticals, according to research published ...

Mar 05, 2013
popularity 5 / 5 (1) | comments 0